Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5285854
Max Phase: Preclinical
Molecular Formula: C21H23N5S
Molecular Weight: 377.52
Associated Items:
ID: ALA5285854
Max Phase: Preclinical
Molecular Formula: C21H23N5S
Molecular Weight: 377.52
Associated Items:
Canonical SMILES: CCCCn1c(SCCc2c[nH]c3ccccc23)nnc1-c1ccncc1
Standard InChI: InChI=1S/C21H23N5S/c1-2-3-13-26-20(16-8-11-22-12-9-16)24-25-21(26)27-14-10-17-15-23-19-7-5-4-6-18(17)19/h4-9,11-12,15,23H,2-3,10,13-14H2,1H3
Standard InChI Key: FAUYSDYUBIKYJV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 377.52 | Molecular Weight (Monoisotopic): 377.1674 | AlogP: 4.96 | #Rotatable Bonds: 8 |
Polar Surface Area: 59.39 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 3.82 | CX LogP: 4.57 | CX LogD: 4.57 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.44 | Np Likeness Score: -1.69 |
1. Yakkala PA, Panda SR, Naidu VGM, Shafi S, Kamal A.. (2023) Pyridine-Based 1,2,4-Triazolo-Tethered Indole Conjugates Potentially Affecting TNKS and PI3K in Colorectal Cancer., 14 (3): [PMID:36923920] [10.1021/acsmedchemlett.2c00475] |
Source(1):